Ramon Merce-Vidal

This inventor holds 18 USPTO granted patents and 1 published patent application and 3 EPO patents, primarily in Medicinal Chemistry. Top assignees: Laboratorios Del Dr. Esteve S.a., Laboratories Del Dr. Esteve S.a., Laboratories Del Sr. Esteve, S.a.. Active years: 1993-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramon Merce-Vidal. Retrieved from https://idiyas.com/inventor/ramon-merce-vidal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 1)

% Patents Active = 66.7

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 74(Granted Patents)

Location History:

Marques de Sentmenat, ES (1995)
Barcelone, ES (2001 - 2002)
Barcelona, ES (1993 - 2012)

Company Filing History:

14 out of 150

Laboratorios Del Dr. Esteve S.a.

patents

3 out of 23

Laboratories Del Dr. Esteve S.a.

patents

1 out of 1

Laboratories Del Sr. Esteve, S.a.

patent

Years Active: 1993-2012

Loading Chart...

Areas of Expertise:

Indene Derivatives

Piperazine Compounds

Thienylazolylalkoxyethanamines

Tetrahydropyridine

Sulfonamide Compounds

Pharmaceutical Compositions

Pain Treatment

Therapeutic Use

Aryl Derivatives

Medicaments

Chemical Preparation

Alkylazoles

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8217041 - Indene derivatives, their preparation and use as medicaments (2012-07-10),

2. 8138210 - Substituted indanyl sulfonamide compounds, their preparation and use as medicaments (2012-03-20),

3. 7964603 - Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments (2011-06-21),

4. 7129361 - Thienylazolylalkoxyethanamines, their preparation and their application as medicaments (2006-10-31),

5. RE39113 - Utilization of derivatives of tetrahydropyridines(or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain (2006-05-29),

6. 6410582 - Thienylazolylalcoxyethanamines, their preparation and their application as medicaments (2002-06-25),

7. 6384055 - Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain (2002-05-07),

8. 6355659 - 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same (2002-03-12),

9. 6346620 - Methods for preparation of 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and salts thereof (2002-02-12),

10. 6303608 - 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use (2001-10-16),

11. 6232329 - Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles (2001-05-15),

12. 5731331 - Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles (1998-03-24),

13. 5536836 - Process for the preparation of (1996-07-16),

14. 5532234 - Use of 1-[4-[4-aryl (or heteroaryl)-1-piperazinyl]-butyl)-1H-azole (1996-07-02),

15. 5444059 - 2-(4-azolylbutyl)-1-piperazinyl)-5-hydroxy-pyrimidine derivatives, their (1995-08-22),

Title: Ramon Merce-Vidal: Innovator in Medicinal Chemistry

Introduction

Ramon Merce-Vidal is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of medicinal chemistry, holding a total of 18 patents. His work primarily focuses on the development of new compounds that have therapeutic applications.

Latest Patents

Among his latest patents, Ramon has developed indene derivatives, which are noted for their preparation and use as medicaments. These new indene derivatives exhibit a general formula (I) and demonstrate affinity for 5-HT receptors, making them effective in treating diseases mediated by these receptors. Another notable patent involves substituted indanyl sulfonamide compounds, which also have a general formula (I). These compounds are prepared for medicinal use and show similar affinity for 5-HT receptors, indicating their potential in therapeutic applications.

Career Highlights

Ramon has worked with notable companies such as Laboratorios del Dr. Esteve S.A. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Ramon has collaborated with several professionals in his field, including Jordi Frigola-Constansa and Juan Pares-Corominas. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Ramon Merce-Vidal is a distinguished inventor whose work in medicinal chemistry has led to the creation of innovative compounds with significant therapeutic potential. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.